Safer sedation for seniors: study pinpoints dose for frail elderly

NCT ID NCT07467603

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at 58 frail elderly patients (65+) to find the best dose of remimazolam, a sedative used for anesthesia. Researchers used a special monitor to track breathing and adjusted doses carefully. The goal is to help doctors give just enough medicine to put patients to sleep without causing breathing problems.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Remimazolam (a short-acting sedative)

What this could lead to

If successful, this could help doctors give safer anesthesia doses to frail older adults, reducing breathing problems.

What could go wrong

This is a small, early-stage study with only 58 people. Results may not apply to all frail elderly patients or those with other health issues.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FRAILTY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Frailty

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Second Hospital of Hebei Medical University

    Shijiazhuang, Hebei, 050000, China